vt3989
vivace therapeutics
['mesothelioma', 'vt3989']
 giving us a really engaging summary of the early clinical work of vt3989 - a compound targeting the hippo pathway... encouraging initial work for mesothelioma. #aacr23 (pp)
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK